期刊文献+

miR-122和miR-144-3p在肾细胞癌中的表达及临床意义 被引量:1

The expression and clinical significance of miR-122 and miR-144-3p in renal cell carcinoma
下载PDF
导出
摘要 目的探讨miR-122和miR-144-3p在肾细胞癌组织中的表达及其临床意义。方法使用实时荧光定量PCR技术检测46例肾细胞癌患者癌组织与癌旁组织中miR-122和miR-144-3p的表达情况,比较二者在癌组织与癌旁组织中的差异。以肾细胞癌组织中miR-122、miR-144-3p的表达水平平均值作为分界,将46例患者分为miR-122低表达和miR-122高表达、miR-144-3p低表达和miR-144-3p高表达,并分析不同年龄、性别、临床病理特征患者中miR-122和miR-144-3p的表达情况。结果miR-122和miR-144-3p在肾细胞癌患者癌组织中的相对表达水平均明显高于癌旁组织,差异有统计学意义(P<0.05)。不同年龄、性别患者miR-122、miR-144-3p低表达百分率分别与miR-122、miR-144-3p高表达百分率比较,差异无统计学意义(P>0.05)。不同TNM分期、临床分期患者miR-122、miR-144-3p低表达百分率分别与miR-122、miR-144-3p高表达百分率比较,差异有统计学意义(P<0.05)。结论miR-122和miR-144-3p在不同TNM分期、临床分期的肾细胞癌患者中表达存在差异,可能在肾细胞癌发生、发展中起重要作用。 Objective To investigate the expression of miR-122 and miR-144-3p in renal cell carcinoma and their clinical significance.Methods The expression changes of miR-122 and miR-144-3p in cancer tissues and para-carcinoma tissue of 46 patients with renal cell carcinoma were detected by real-time quantitative PCR technique,and the differences on these two indicators in cancer tissues and para-carcinoma tissues were compared.The mean expression levels of miR-122 and miR-144-3p in renal cell carcinoma tissues were used as the dividing line.All 46 patients were divided into low expression level of miR-122 and high expression level of miR-122,low expression level of miR-144-3p and high expression level of miR-144-3p,and the expression status of miR-122 and miR-144-3p in patients with different ages,genders,clinic and pathological characteristics were analyzed.Results The relative expression levels of miR-122 and miR-144-3p in cancer tissues of patients with renal cell carcinoma were significantly higher than those in para-carcinoma tissue(P<0.05).There was no statistical significance between the low expression percentage of miR-122,miR-144-3p and the high expression percentage of miR-122,miR-144-3p in patients with different ages and genders(P>0.05).The low expression percentage of miR-122 and miR-144-3p had statistically significant different with the high expression percentage of miR-122 and miR-144-3p respectively in patients with different TNM stages and clinical stages(P<0.05).Conclusion The expressions of miR-122 and miR-144-3p are different in patients with renal cell carcinoma with different TNM stages and clinical stages,which might play an important role in the occurrence and development of renal cell carcinoma.
作者 祝金波 王敏 周林 刘毓玲 ZHU Jinbo;WANG Min;ZHOU Lin;LIU Yuling(Department of Clinical Laboratory,Wuhan Traditional Chinese Medicine Hospital,Wuhan,Hubei 430050,China)
出处 《国际检验医学杂志》 CAS 2021年第10期1250-1253,共4页 International Journal of Laboratory Medicine
基金 湖北省武汉市卫生健康委员会医学科研项目(WZ19C37)。
关键词 肾细胞癌 MIR-122 miR-144-3p 肿瘤标志物 renal cell carcinoma miR-122 miR-144-3p tumor markers
  • 相关文献

参考文献5

二级参考文献21

  • 1Aram S Modrek,N Sumru Bayin,Dimitris G Placantonakis.Brain stem cells as the cell of origin in glioma[J].World Journal of Stem Cells,2014,6(1):43-52. 被引量:14
  • 2Sudarshan S, Karam JA, Brugarolas J, et al. Metabolism of kidney cancer : from the lab to clinical practice[J]. Eur Urol, 2013,63 (2) : 244.
  • 3Qayyum T, Oades G, Horgan P, et al. The epidemiology and risk factors for renal cancer[J]. Curr Urol,2013,6(4): 169.
  • 4Pichler M, Calin GA. MicroRNAs in cancer=from developmental genes in worms to their clinical application in patients[J]. Br J Cancer,2015,113(4) :569.
  • 5Calin GA,Croce CM. MicroRNA signatures in human cancers[J]. Nat Rev Cancer,2006,6(11) :857.
  • 6Yamada H, Ohashi K, Suzuki K, et al. Longitudinal study of circu- lating miR-122 in a rat model of non-alcoholic fatty liver disease [J]. Clin Chim Acta,2015,446:267.
  • 7Roderburg C,Benz F,Vargas Cardenas D,et al. Elevated miR 122 serum levels are an independent marker of liver injury in inflam- matory diseases[J]. Liver Int,2015,35(4) : 1172.
  • 8Thakral S, Ghoshal K. miR 122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimir[J]. Curr Gene Ther, 2015,15 (2) : 142.
  • 9Bandiera S, Pfeffer S, BaumerI T F, et al. miR 122 a key factor and therapeutic target in liver disease[J]. J Hepatol,2015,62(2) : 448.
  • 10INassirpour R, Mehta PP, Yin MJ. miR-122 regulates tumorigene sis in hepatocellular carcinoma by targeting AKT3[J]. PLoS One, 2013,8(11) : e79655.

共引文献11

同被引文献1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部